匿名在线麻醉者:解决甲基使用障碍的选择
Journal of addiction medicine
|October 31, 2025
概括
在线无名麻醉者 (NA) 会议可以支持甲基胺使用障碍 (MUD) 患者的缓解. 在NA内部的主观经验与恢复成功有关,这表明专业推的实用性.
科学领域:
- 成 药物 药物 药物 药物
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 甲基胺过量死亡是美国的重大公共卫生问题.
- 甲基胺使用障碍 (MUD) 的有效治疗方法有限.
- 在线无名麻醉者 (NA) 的参与可能会为MUD缓解提供一个可访问的支持系统.
研究的目的:
- 调查在线NA参与在促进MUD患者缓解治疗中的作用.
- 描述MUD患者在线NA的临床状况和康复经验.
主要方法:
- 对访问在线NA会议的个人进行了匿名在线调查.
- 调查数据包括临床状态,物质使用模式和以前的网站经验.
- 分析了356名参与者的回答,他们认为甲基胺是他们主要的毒品问题.
主要成果:
- 在患有MUD的参与者中,44%是网上网站的新人,44%是长期戒断者 (平均2.3年),13%仍在使用甲基胺.
- 主观经验,包括对12步的信仰,精神觉醒和应急缓解,与缓解有关.
- 在线NA参与在MUD个体中显示出不同程度的参与和缓解.
结论:
- 在线NA会议可以成为支持MUD患者戒断的宝贵资源.
- 该研究强调了在线NA对专业推的潜在实用性,并要求进一步调查.
- 了解在线NA中的主观经验可以为MUD的治疗策略提供信息.
更多相关视频
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.5K
08:53Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
Published on: May 31, 2019
5.5K
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Drug Dependence
1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Substance Use Disorders Affecting Sleep
394
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
394
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
758
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
758
Opioid Analgesics: Synthetic and Semisynthetic Opioids
906
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
906
Adrenergic Agonists: Mixed-Action Agents
1.4K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.4K
